Navigating the Nuances: Exploring Imaging Options and Impact to Treatment Strategies in nmCRPC - Ryan Malone
Zach Klaassen and Ryan Malone discuss the management of Nonmetastatic castration-resistant prostate cancer (nmCRPC), focusing on the evolving role of PSMA PET imaging.
The Biological Basis of Metastatic Prostate Cancer – The Unmet Medical Need for New Targets and Novel Treatment Pathways - Dan George
Daniel George
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPCPart of an Independent Medical Education Initiative Supported by LOXO@LillyBiographies:Daniel George, MD, Medical Oncologist, Professor, Departments of Medicine and Surgery, Leader, DCI Center for Prostate and Urologic Cancers, Duke Cancer Institute, Duke University, Durham, NC